| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/31/2007 | WO2006078294A3 Alphavirus vectors for respiratory pathogen vaccines |
| 05/31/2007 | WO2006076021A3 Cd44 variants as therepeutic targets |
| 05/31/2007 | WO2006069290A3 Enzymes for starch processing |
| 05/31/2007 | WO2006057832A3 Cytokinin-sensing histidine kinases and methods of use |
| 05/31/2007 | WO2006050732A3 Lna oligonucleotides and the treatment of cancer |
| 05/31/2007 | WO2006042232A3 Targeted trans-splicing of highly abundant transcripts for in vivo production of recombinant proteins |
| 05/31/2007 | WO2006033854A3 Aptamers to von willebrand factor and their use as thrombotic disease therapeutics |
| 05/31/2007 | WO2006023544A3 Therapeutic uses of inhibitors of rtp801 |
| 05/31/2007 | WO2005060515A3 An oncolytic adenovirus |
| 05/31/2007 | WO2005021733A3 Methods and compositions for sirna expression |
| 05/31/2007 | WO2005003316A3 Rna processing protein complexes and uses thereof |
| 05/31/2007 | US20070124838 Expression of the human igf-1 in transgenic plastids |
| 05/31/2007 | US20070124837 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 05/31/2007 | US20070124836 Methods for genetic control of insect infestations in plants and compositions thereof |
| 05/31/2007 | US20070124835 Method for producing a transgenic plant with the aid of agrobacterium thumefaciens |
| 05/31/2007 | US20070124834 Expression vector comprising nucleotide sequences which code plant regulatory sequences; for use in controlling root length, senecense and/or water and nutrient uptake |
| 05/31/2007 | US20070124833 Genes and uses for plant improvement |
| 05/31/2007 | US20070124832 Bioreactor containing cells expressing glycosyltransferase nucleic acids |
| 05/31/2007 | US20070124831 Plant transformation with in vivo assembly of a trait |
| 05/31/2007 | US20070124830 Plastid genetic engineering via somatic embryogenesis |
| 05/31/2007 | US20070124825 Use of hepcidin as a regulator of iron homeostasis |
| 05/31/2007 | US20070124088 Automatic threshold setting and baseline determination for real-time PCR |
| 05/31/2007 | US20070124087 Automatic threshold setting and baseline determination for real-time PCR |
| 05/31/2007 | US20070123699 Peptide conjugate useful for cell nucleus molecular imaging and tumor therapy |
| 05/31/2007 | US20070123487 Methods and Compositions for Treating Prostate Cancer Using DNA Vaccines |
| 05/31/2007 | US20070123485 Introduction of double-stranded short interference RNA into the cells and reducing the expression of the corresponding messenger RNA in the cells; for inhibiting expression of a target gene in a cell |
| 05/31/2007 | US20070123484 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 05/31/2007 | US20070123481 Antisense IAP oligonucleotides and uses thereof |
| 05/31/2007 | US20070123463 screening for drugs that reduce or enhance sensitivity to insulin and/or leptin, thereby modulating carbohydrate metabolism such as increasing or decreasing blood glucose levels, glucose uptake into cells and assimilation into glycogen; dietetics and antidiabetic agents |
| 05/31/2007 | US20070123459 IL-17 like molecules and uses thereof |
| 05/31/2007 | US20070123457 Carrier chimeric proteins, targeted carrier chimeric proteins and preparation thereof |
| 05/31/2007 | US20070123456 Novel regulator of endothelial cell function and vessel remodeling |
| 05/31/2007 | US20070123455 Immunomodulatory agents for treatment of inflammatory diseases |
| 05/31/2007 | US20070122908 Molecular Delivery to Cells Using Aspirin-Related Compounds |
| 05/31/2007 | US20070122904 Method and apparatus for culturing cells |
| 05/31/2007 | US20070122899 Target substance analysis apparatus and determination software update method |
| 05/31/2007 | US20070122895 Genetic engineered polypeptide with specific amino acid sequence, to identify a secretory signal sequence native to Pichia methanolica to enable the use of methylotrophic yeasts for production of polypeptides |
| 05/31/2007 | US20070122887 Gene variants coding for proteins from the metabolic pathway of fine chemicals |
| 05/31/2007 | US20070122885 Methods of increasing production of secondary metabolites by manipulating metabolic pathways that include methylmalonyl-coa |
| 05/31/2007 | US20070122883 Nucleotide sequences coding orphan receptor component of multimeric complex for use in identifying modulator for prevention and treatment of cell proliferative disorders |
| 05/31/2007 | US20070122882 Gene specifically expressed in postmitotic dopaminergic neuron precursor cells |
| 05/31/2007 | US20070122881 Rhamnose-inducible expression systems and methods |
| 05/31/2007 | US20070122879 for detecting and treating viral infections in in vitro and in vivo; ligand-binding receptor polypeptides can also be used to block ligand activity in vitro and in vivo; for forming a heterodimeric receptor complex with IL-28R and CRF2-4 |
| 05/31/2007 | US20070122876 Nucleic acids for enhancing gene expression and use thereof |
| 05/31/2007 | US20070122875 Enzyme for decomposition of sulfated fucan derived from sea cucumber |
| 05/31/2007 | US20070122871 Microbial strains producing sphingosine |
| 05/31/2007 | US20070122868 Drug screening; identifying potential biological targets for fungicides and for isolating genes coding for proteins controlling biochemical functions essential to the pathogenesis of the fungus Magnaporthe grisea with respect to rice and barley |
| 05/31/2007 | US20070122866 Protein having PGE2 synthase activity and use thereof |
| 05/31/2007 | US20070122865 Enzymes and enzymic processes |
| 05/31/2007 | US20070122851 Novel fluorescent and colored proteins, and polynucleotides that encode these proteins |
| 05/31/2007 | US20070122846 Anti-human mitochondrial adenylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease |
| 05/31/2007 | US20070122837 Mothod for the synthesis of DNA sequences |
| 05/31/2007 | US20070122832 Process for Preparing L-amino Acids |
| 05/31/2007 | US20070122822 Compositions and methods for enhancing oligonucleotide-directed nucleic acid sequence alteration |
| 05/31/2007 | US20070122812 Method of screening for protein secretion recombinant host cells |
| 05/31/2007 | US20070122810 Brain tumor marker and method of diagnosing brain tumor |
| 05/31/2007 | US20070122809 Nucleic acid isolation |
| 05/31/2007 | US20070122807 Posh polypeptides, complexes and related methods |
| 05/31/2007 | US20070122802 Methods of diagnosing and treating diabetes and insulin resistance |
| 05/31/2007 | US20070122798 Methods and tools for screening active rna in cellulo |
| 05/31/2007 | US20070122795 Information processing apparatus, information processing method, information processing system, program, and recording medium |
| 05/31/2007 | US20070122428 Genetically modified cholera toxin (CT-CRM) comprising reduced toxicity and enhanced immunological response for use in preparation of vaccines against parasitic infection |
| 05/31/2007 | US20070122427 Delivery of trefoil peptides |
| 05/31/2007 | US20070122425 fusion protein comprising a periplasmic targeting signal and at least one antimicrobial peptide; use as microbiocides; from Gram negative bacteria transformed host cell; nontoxic and proteolytic non-degradation, simple, inexpensive recovery of the peptide; industrial scale production; on medical devices |
| 05/31/2007 | US20070122423 Derp1 and proderp1 allergen derivatives |
| 05/31/2007 | US20070122422 Sodium-independent small neutral amino acid transporter transporting L- and D- amino acids |
| 05/31/2007 | US20070122412 Eg-vegf nucleic acids and polypeptides and methods of use |
| 05/31/2007 | US20070122403 Molecules with extended half-lives, compositions and uses thereof |
| 05/31/2007 | US20070122394 administering a VEGFR modulating agent that comprises placental growth factor; a growth factor that binds and activates Flt-1 such as PIGF or VEGF-B, an anti-Flt-1 agonistic antibody or a small molecule agonist |
| 05/31/2007 | US20070122391 Compositions and methods for non-targeted activation of endogenous genes |
| 05/31/2007 | US20070122385 Replication competent viruses capable of silencing virus inhibitory factor expression |
| 05/31/2007 | US20070122380 Chimeric cytokine of IL-7 and beta-chain of HGF and methods of use |
| 05/31/2007 | US20070121111 Imaging of Biological Samples |
| 05/31/2007 | DE102005057643A1 Bacterial vaccine that allows differentiation between infected and vaccinated animals, particularly pigs, comprises knock-out mutations in at least three genes, one encoding an immunogenic protein that serves as marker |
| 05/31/2007 | CA2790802A1 Immunostimulatory oligoribonucleotides |
| 05/31/2007 | CA2634187A1 Chimeric keratin-binding effector proteins |
| 05/31/2007 | CA2631015A1 Human monoclonal antibody human cd134 (ox40) and methods of making and using same |
| 05/31/2007 | CA2630929A1 Chimeric, hybrid and tandem polypeptides of meningococcal nmb1870 |
| 05/31/2007 | CA2630770A1 Recombinant polyvalent vaccine |
| 05/31/2007 | CA2630738A1 Immunostimulatory oligoribonucleotides |
| 05/31/2007 | CA2630668A1 Intraocular pressure-regulated early genes and uses thereof |
| 05/31/2007 | CA2630652A1 Bioassays |
| 05/31/2007 | CA2630629A1 Methods and proteins for the prophylactic and/or therapeutic treatment of the four serotypes of dengue virus and other flaviviruses |
| 05/31/2007 | CA2630602A1 Modulation of eif4e-bp2 expression |
| 05/31/2007 | CA2630445A1 Enzyme preparations yielding a clean taste |
| 05/31/2007 | CA2629147A1 Humanized immunoglobulin reactive with .alpha.4.beta.7 integrin |
| 05/31/2007 | CA2628530A1 Novel stem cells, nucleotide sequences and proteins therefrom |
| 05/31/2007 | CA2628313A1 Composition and method for efficient delivery of nucleic acids to cells using chitosan |
| 05/31/2007 | CA2627443A1 Dna constructs for specific inhibition of gene expression by rna interference |
| 05/31/2007 | CA2625855A1 Delta-9 elongases and their use in making polyunsaturated fatty acids |
| 05/31/2007 | CA2624661A1 Delta-9 elongases and their use in making polyunsaturated fatty acids |
| 05/31/2007 | CA2621705A1 Erythropoietin polypeptides and uses thereof |
| 05/30/2007 | EP1790983A1 Method of screening compound preventing cells from infection with hepatitis c virus (hcv) |
| 05/30/2007 | EP1790736A2 Massive parallel method for decoding DNA and RNA |
| 05/30/2007 | EP1790731A2 Process for the production of delta 5-unsaturated fatty acids in transgenic organisms |
| 05/30/2007 | EP1790730A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/30/2007 | EP1790729A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/30/2007 | EP1790728A2 Imaging, diagnosis and treatment of disease |
| 05/30/2007 | EP1790727A2 Proteins and nucleic acids encoding same |
| 05/30/2007 | EP1790726A2 Modified and stabilized GDF propeptides and uses thereof |